HomeStock ScreenerMahamaya Lifesciences

Mahamaya Lifesciences Share Price | Mahamaya Lifesciences Stock Screener

MAHALIFE Pesticides & Agrochemicals
Track Mahamaya Lifesciences share price live with TickJournal's free stock screener. Check MAHALIFE 52-week high low for the annual price range and momentum. Use the Mahamaya Lifesciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Mahamaya Lifesciences Market Cap ₹433.00 Cr.
MAHALIFE P/E Ratio (TTM) 33.45
Mahamaya Lifesciences P/B Ratio 3.81
EPS (TTM) ₹7.60
Dividend Yield -
Debt to Equity 1.52
MAHALIFE 52 Week High -
Mahamaya Lifesciences 52 Week Low -
Operating Margin 8.00%
Profit Margin 5.00%
MAHALIFE Revenue (TTM) ₹120.00
EBITDA ₹12.00
Net Income ₹6.00
Total Assets ₹188.00
Total Equity ₹49.00

Mahamaya Lifesciences Share Price Chart

Screen Mahamaya Lifesciences share price with an interactive chart. Analyse MAHALIFE price trends and volatility across different timeframes.

Mahamaya Lifesciences Company Profile - Fundamental Screener

Screen Mahamaya Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MAHALIFE shares.
Sector Chemicals
Industry Pesticides & Agrochemicals
Sub-Sector Pesticides & Agrochemicals
Segment E
ISIN INE0U9D01019

Mahamaya Lifesciences Balance Sheet Screener

Screen MAHALIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022
Assets
Total Assets 188 112 78 56
Current Assets 157 87 54 33
Fixed Assets 27 22 21 20
Liabilities
Total Liabilities 0 0 0 0
Current Liabilities 7 9 11 10
Non-Current Liabilities 0 0 0 0
Shareholders' Equity
Total Equity 49 25 19 16
Share Capital 18 1 1 1
Reserves & Surplus 32 23 18 15

Mahamaya Lifesciences Income Statement Screener - Profit & Revenue Analysis

Screen Mahamaya Lifesciences income statement and profit fundamentals. Analyze MAHALIFE quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Mahamaya Lifesciences share price evaluation.
Item 2025-Mar 2024-Dec
Revenue 120 0
Expenses 108 0
EBITDA 12 0
Operating Profit % 8.00% 0.00%
Depreciation 1 0
Interest 3 0
Profit Before Tax 7 0
Tax 2 0
Net Profit 6 0
EPS 3.11 0.00

Mahamaya Lifesciences Cash Flow Screener - Liquidity Fundamentals

Screen MAHALIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March
Operating Activities 1 -23 1 2
Investing Activities -8 -2 -3 -3
Financing Activities 9 24 2 1
Net Cash Flow 1 0 1 0

Mahamaya Lifesciences Shareholding Pattern Screener

See Mahamaya Lifesciences shareholding pattern with promoter, FII, and DII holdings. Check Mahamaya Lifesciences promoter holding and ownership changes for MAHALIFE on TickJournal.
Item 2026-Mar 2025-Feb 2025-Oct 2025-Nov
Promoter Holding 56.35% 77.27% 77.27% 56.35%
FII Holding 4.77% 0.00% 0.00% 6.39%
DII Holding 2.52% 0.00% 0.00% 4.67%
Govt Holding 0.00% 0.00% 0.00% 0.00%
Public Holding 10.65% 0.00% 0.00% 12.72%
Other Holding 25.71% 22.73% 22.73% 19.88%
Shareholder Count 584 18 18 1,034

Mahamaya Lifesciences Share Dividend Screener - Share Yield Analysis

Check Mahamaya Lifesciences dividend history with payout and yield data. View Mahamaya Lifesciences dividend details including ex-dates and amounts for MAHALIFE stock.
No dividends declared by Mahamaya Lifesciences.

Mahamaya Lifesciences Stock Index Membership

See which indices include Mahamaya Lifesciences stock. Check MAHALIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Mahamaya Lifesciences is not part of any tracked indices.
Only major market indices are tracked in our system.

Mahamaya Lifesciences Market Events Screener - Corporate Actions

Get Mahamaya Lifesciences corporate actions including splits, bonuses, and buybacks. Check Mahamaya Lifesciences stock events that may affect MAHALIFE share price.
Announcement Date Record Date Event Type Information Price Impact
2025-12-02 2025-12-02 Quarterly Result Announcement NA -0.69%

Mahamaya Lifesciences Competitors Screener - Peer Comparison

Screen MAHALIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
UPL 53,373 24.03 51,839 10.01% 1,914 46.50
PI Industries 47,259 32.55 8,322 5.70% 1,660 57.10
Sumitomo Chemical 22,898 43.02 3,269 11.19% 506 54.92
Bayer Crop Science 19,549 29.16 5,593 7.89% 568 30.58
Sharda Cropchem 8,742 12.85 5,268 20.28% 716 39.53
Rallis 5,128 31.33 2,631 6.54% 164 53.04
Dhanuka Agritech 4,884 16.41 2,071 15.49% 297 57.82
NACL Industries 3,781 809.75 1,584 27.51% 10 49.81
Bhagiradha Chemicals & Industries 3,229 242.16 450 9.63% 14 54.05
Bharat Rasayan 2,294 17.35 1,199 12.53% 141 43.13

Mahamaya Lifesciences Company Announcements - News Screener

Screen MAHALIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-05-19 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-05-05 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-04 Intimation Under Regulation 30 (LODR)_Certificate Of Appreciation -
2026-04-28 Announcement Under Regulation 30(LODR)-Receiving A Certification-"Great Place To Work" -
2026-04-15 Non-Applicability Of The Compliance On Corporate Governance As Required Under Regulation 27(2) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-04-04 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-03 Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation 2011 -
2026-03-30 Closure of Trading Window -
2026-03-10 Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 -Utilisation Of Unutilised IPO Proceeds In Subsequent Fiscal Years. -
2026-03-09 Announcement Under Regulation 30 (LODR)-Intimation Of Withdrawn Of Participation In Virtual Conference On Monday 9" March 2026. -
2026-03-05 Intimation Of Participation In Arihant Capital Bharat Connect Virtual Conference Rising Star 2026 On Monday 9Th March 2026. -
2026-02-17 Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel (SMP) -
2026-02-17 Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel (SMP) -
2026-01-22 Announcement Under Regulation 30 - Receiving A Prestigious Award - Company Of The Year - Medium Scale At ICSCE 2026 Dubai -
2026-01-16 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-01-16 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-02 Submission Of Half Yearly Financial Results - September 2025 -
2025-12-02 Board Meeting Outcome for Submission Of Half Year Results - September 2025 -
2025-11-26 Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results -
2025-11-24 Closure of Trading Window -